SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues
The DOI matches its Crossref record; 7 of the 8 references it cites were found in a registry or an index.
Abstract
Sry-related HMg-Box gene 10 (SOX10) is a nuclear transcription factor that plays an important role in melanocytic cell differentiation. It has been shown to be a sensitive marker of melanoma including spindle and desmoplastic subtypes. We assessed its frequency of expression in melanoma, carcinoma, benign nevi, and non-neoplastic tissues with routine immunohistochemistry for SOX10. The 109 primary melanoma included 49 epithelioid, 19 spindle cell, 22 desmoplastic, and 19 mixed spindle cell/desmoplastic melanoma. All primary, except 8 desmoplastic melanoma, and 11 metastatic melanoma were strongly and diffusely nuclear SOX10-positive. Six desmoplastic melanoma had ≤10% cells positive, and 2 were <50% positive, all of 3+ intensity. Eighteen of 149 (12%) breast carcinoma were SOX10-positive. All 24 ovarian, 23 endometrial, 26 lung, and 25 colon carcinoma were SOX10-negative. All 43 benign nevi, 18 dysplastic nevi, 68 non-neoplastic and benign skins, and all 56 non-neoplastic breast tissue were SOX10-positive. The sensitivity and specificity for SOX10 in the diagnosis of melanoma are 1.0 and 0.93, respectively; the positive and negative predictive values are 0.87 and 1.0, respectively. SOX10 is a sensitive, specific marker for melanoma. As benign nevi also express SOX10, it cannot be used to differentiate between benign and malignant pigmented skin lesions. Only a small number of breast carcinoma (12%), and breast lobules, express SOX10; no carcinoma of the ovary, endometrium, lung, or colon expressed SOX10.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while some NCSC factors, such as SOX10 and YY1, are activated upon melanoma formation and are required for melanoma growth16,19,29,69”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [69]
Citations
Cites
Bowles, J., Schepers, G., & Koopman, P. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9883 · Cited by 966
Sox10: A Pan-Schwannian and Melanocytic Marker
Nonaka, D., Chiriboga, L., & Rubin, B. P. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181658c14 · Cited by 405
Mollaaghababa, R., & Pavan, W. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206442 · Cited by 222
Orchard, G. E. (2000) · The Histochemical Journal · doi:10.1023/a:1004192232357 · Cited by 148
Ultrastructural localization of HMB‐45 binding sites
Schaumburg‐Lever, G., Metzler, G., & KAISERLING, E. (1991) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1991.tb01380.x · Cited by 73
Matthew D. Perry, M. D., Hf, S., & Johnston, W. W. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.5.1013 · Cited by 45
Friedman, H. D., & Tatum, A. H. (1991) · PubMed · Cited by 29
Cited by
Miettinen, M., McCue, P. A., Sarlomo-Rikala, M., Biernat, W., Czapiewski, P., Kopczynski, J., Thompson, L. D., Lasota, J., Wang, Z., & Fetsch, J. F. (2015) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000398 · Cited by 305
Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
Prieto-Granada, C. N., Wiesner, T., Messina, J. L., Jungbluth, A. A., Chi, P., & Antonescu, C. R. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000564 · Cited by 294
SOX10: A Useful Marker for Identifying Metastatic Melanoma in Sentinel Lymph Nodes
Willis, B. C., Johnson, G., Wang, J., & Cohen, C. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000097 · Cited by 99
Self-citationSOX10 Promotes Melanoma Cell Invasion by Regulating Melanoma Inhibitory Activity
Graf, S. A., Busch, C., Bosserhoff, A., Besch, R., & Berking, C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.128 · Cited by 101
“SOX10 has been established as a sensitive marker for melanocytic lesions, with positive staining in nevi and melanoma (Nonaka et al., 2008; Mohamed et al., 2012).”
BackgroundTRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma
Yoon, E. C., Wang, G., Parkinson, B., Huo, L., Peng, Y. S., Wang, J., Salisbury, T., Wu, Y., Chen, H., Albarracin, C. T., et al. (2022) · Human Pathology · doi:10.1016/j.humpath.2022.04.006 · Cited by 96
Self-citation
Metadata
- Authors
- Mohamed, A., Gonzalez, R. S., Lawson, D., Wang, J., & Cohen, C.
- Affiliations
- Emory University (US)
- Venue
- Applied Immunohistochemistry & Molecular Morphology
- Published
- 2013-12
- Volume
- 21
- Issue
- 6
- Pages
- 506-510
- ISSN
- 1533-4058 (ISSN-L)
- 1541-2016
- OpenAlex
- W2037033919
- Cited by
- 159
- References
- 8
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 12 · 2022: 20 · 2021: 9 · 2020: 16 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 15 · 2015: 11 · 2014: 12 · 2013: 3
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Applied immunohistochemistry & molecular morphology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- SOX10, melanoma, desmoplastic melanoma, spindle cell melanoma, epithelioid melanoma, melanocyte differentiation, benign nevi, dysplastic nevi, breast cancer, sensitivity and specificity, metastatic melanoma, ovarian carcinoma, endometrial cancer, lung cancer, colon cancer
- MeSH terms
- Cutaneous Malignant Melanoma, Melanoma, Cutaneous Malignant, Breast Neoplasms, Carcinoma, Colonic Neoplasms, Female, Humans, Immunohistochemistry, Lung Neoplasms, Male, Melanoma, Nevus, Ovarian Neoplasms, Sensitivity and Specificity, Skin Neoplasms, Biomarkers, Tumor, Gene Expression, Case-Control Studies, Endometrial Neoplasms, SOXE Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues. https://app.cochat.ai/papers/10.1097/pai.0b013e318279bc0a
- The paper
- Mohamed, A., Gonzalez, R. S., Lawson, D., Wang, J., & Cohen, C. (2013). SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues. Applied Immunohistochemistry & Molecular Morphology. https://doi.org/10.1097/pai.0b013e318279bc0a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.